Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna C Calkin

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Science Translational Medicine|September 10, 2010
Genome-wide association studies identify new targets in cardiovascular diseaseAnna C Calkin, Peter Tontonoz
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
Liver x receptor signaling pathways and atherosclerosisAnna C Calkin, Peter Tontonoz
Nature Reviews. Molecular Cell Biology|March 15, 2012
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXRAnna C Calkin, Peter Tontonoz
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2017
The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and AtherosclerosisEser J Zerenturk, Anna C Calkin
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2007
Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonistBrian G Drew, Anna C Calkin
Circulation Research|June 9, 2018
The CCC Complex COMManDs Control of LDL Cholesterol LevelsMichael F Keating, Anna C Calkin
Nature Medicine|September 11, 2007
The clot thickens--oxidized lipids and thrombosisShaun P Jackson, Anna C Calkin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 24, 2006
Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological inventionAnna C Calkin, Terri J Allen
PPAR Research|February 22, 2008
PPAR Agonists and Cardiovascular Disease in DiabetesAnna C Calkin, Merlin C Thomas
Clinical Science (London, England : 1979)|June 9, 2017
Thrombosis in diabetes: a shear flow effect?Erik Westein, Thomas Hoefer, Anna C Calkin
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|September 10, 2010
Genome-wide association studies identify new targets in cardiovascular diseaseAnna C Calkin, Peter Tontonoz
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
Liver x receptor signaling pathways and atherosclerosisAnna C Calkin, Peter Tontonoz
Nature Reviews. Molecular Cell Biology|March 15, 2012
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXRAnna C Calkin, Peter Tontonoz
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2017
The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and AtherosclerosisEser J Zerenturk, Anna C Calkin
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2007
Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonistBrian G Drew, Anna C Calkin
Circulation Research|June 9, 2018
The CCC Complex COMManDs Control of LDL Cholesterol LevelsMichael F Keating, Anna C Calkin
Nature Medicine|September 11, 2007
The clot thickens--oxidized lipids and thrombosisShaun P Jackson, Anna C Calkin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 24, 2006
Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological inventionAnna C Calkin, Terri J Allen
PPAR Research|February 22, 2008
PPAR Agonists and Cardiovascular Disease in DiabetesAnna C Calkin, Merlin C Thomas
Clinical Science (London, England : 1979)|June 9, 2017
Thrombosis in diabetes: a shear flow effect?Erik Westein, Thomas Hoefer, Anna C Calkin
Pageof 6